#Japan #Tokyo #Embox #HIX #Hatchobori

Embox Relocates Headquarters to H¹O Hatchobori

Embox Inc., a Tokyo-based healthcare startup on a mission to innovate self-medication through technology, announced its relocation to H¹O Hatchobori, effective May 1, 2025. This strategic move aims to support future business expansion and enhance recruitment efforts. By fostering improved communication among employees, Embox seeks to elevate productivity and corporate value.

About the New Office

• - Address: 302, H¹O Hatchobori, 2-3-9 Hatchobori, Chuo-ku, Tokyo, 104-0032
• - Opening Date: May 1, 2025
• - Access: The new office is conveniently located within a short walk from several subway stations:

- 3 minutes from "Takaracho" Station on the Toei Asakusa Line
- 4 minutes from "Hatchobori" Station on Tokyo Metro Hibiya Line
- 7 minutes from "Kyobashi" Station on Tokyo Metro Ginza Line
- 10 minutes from "Tokyo" Station (JR lines)

For a detailed location, please refer to this map.

Embox's former headquarters, located at 1-20-10 Sugamo, Toshima-ku, Tokyo, will continue to operate as a retail outlet for pharmaceuticals.

Features of the New Office Space

Opened in March 2025, H¹O Hatchobori offers more than just workspaces. The facility includes spacious lounges and a rooftop terrace, designed to encourage employees to actively exchange ideas and collaborate in a vibrant environment. The photographs provided by the official H¹O Hatchobori website highlight these attractive communal spaces:

• - 1F Lounge: A welcoming area for employees to gather.
• - 2F Lounge: Additional space for meetings and social interactions.
• - Rooftop Terrace: An inspiring outdoor area for relaxation and brainstorming.

Driving Forces Behind the Move

Embox is recognized for its innovative self-care brand, HIX, which focuses on the management of AGA (androgenetic alopecia). The startup not only develops and sells a management app for AGA but also specializes in correlating products and services to enhance user experience.

Looking ahead, Embox plans to go beyond the AGA sector, diversifying into other health-related areas. The company aspires to deliver a new generation of self-medication experiences by combining digital technology with pharmaceutical products.

The decision to relocate was prompted by the need for an environment that facilitates sufficient workspace for each employee, while encouraging cross-departmental interactions. This aligns with Embox's goal of creating a dynamic office culture, pivotal for the company’s growth trajectory.

Additionally, the new location is strategically placed near Nihonbashi, historically known as the "medicine town" of Japan, reinforcing Embox's commitment to its mission of innovating self-medication through technology.

A Glimpse into Embox

Founded on November 1, 2018, Embox Inc. focuses on leveraging technology to enhance patient experiences throughout their healthcare journeys. The startup offers various services that address challenges faced by patients at different stages, from initial disease awareness to diagnosis and treatment. Currently, Embox showcases their AGA self-care brand, HIX, operating an AGA management app and a range of associated products.

• - Company Name: Embox Inc.
• - CEO: Daisuke Kanazawa
• - Headquarters: 302, H¹O Hatchobori, 2-3-9 Hatchobori, Chuo-ku, Tokyo, 104-0032
• - Business Established: November 1, 2018
• - Services Offered: Development and management of the AGA management app "HIX" and sales of the first-class pharmaceutical "HIX Minoxidil 5".

For further details, visit the corporate website at Embox Inc. or explore the official HIX site at HIX Self Check.